Tag: Minnesota

Latest News

Website errors raise calls for Medicare to Be flexible with seniors’ enrollment

Newsemia
Beneficiaries are going to be able to change plans next year because of misinformation through the website for Medicare enrollment although officials provided few details....
Latest News

What will it take to improve recruitment for clinical trials?

Newsemia
Whether clinical trial travel requires a short rideshare trip or a flight halfway across the world, the key to keeping participants enrolled and engaged is...
Latest News

Angion’s kidney therapy advances

Newsemia
The 28-patient study showed that Angion’s drug improved kidney function, based on patients’ estimated glomerular filtration rate (eGFR), a key renal function metric. Source link...
Latest News

Why Google is buying Fitbit

Newsemia
We spoke to investors and analysts to figure out why Google is buying Fitbit, a company that hasn’t made much of a dent in the...
Latest News

Amgen to stop selling Repatha at higher list price, offer low-priced option exclusively

Newsemia
The biotech company had kept the drug available at the higher list price in order to give payers and pharmacy benefit managers time to adjust...
Latest News

Download the HLTH app to maximize your networking game

Newsemia
In its second year, HLTH is offering a smorgasbord of programs designed to facilitate networking at its conference at the MGM Grand in Las Vegas October...
Latest News

Get ready for the second annual HLTH conference

Newsemia
MedCity’s patient engagement conference ENGAGE will be part of the HLTH conference for the first time this year. ENGAGE at HLTH on October 28 will feature innovators from...
Latest News

UCB psoriasis drug beats J&J’s second top-selling product in Phase III study

Newsemia
Results of the BE VIVID study showed that UCB’s bimekizumab showed a statistically significant improvement in skin clearance compared with J&J’s Stelara and placebo. Source...
Latest News

Whistleblower alleges Medicare fraud at iconic Seattle-based health plan

Newsemia
The Justice Department has thus far declined to take over the case, which alleges wrongdoing by Seattle-based nonprofit health plan, Group Health, but said in...
Latest News

A look at the different ways in which HIPAA is enforced

Newsemia
Although historically they have been infrequent, the pace of settlements from attorneys general has picked up over recent years. Source link...
Latest News

Emmaus withdraws European application for sickle cell drug that got US approval

Newsemia
The company said it would withdraw the application for Xyndari after the EMA’s Committee for Medicinal Products for Human Use followed a negative opinion from...
Latest News

Comprehensive managed vision care is more than mere “medical management”

Newsemia
As U.S. healthcare continues to evolve, understanding true utilization management is critical now more than ever and managed vision care serves as an opportunity for...
Latest News

Your guide to networking events at HLTH

Newsemia
Here’s a roundup of networking opportunities at the healthcare innovation conference in Las Vegas October 27-30 at the MGM Grand. Source link...
Latest News

The business case for integrating claims and clinical data 

Newsemia
By partnering with a smart, secure, and collaborative health data network, providers and health plans can access integrated claims and clinical data and more effectively transition to...
Latest News

Sanofi’s billion-dollar multiple sclerosis drug faces competitive threat from Novartis, J&J agents

Newsemia
On Friday, Novartis presented data at ECTRIMS showing that Arzerra had superior efficacy to Sanofi’s Aubagio. Johnson & Johnson’s Janssen division had presented data for...
Latest News

You are where you work

Newsemia
Moving away from the sick care toward primary care is not only a more efficient way to address social determinants of health in the workplace,...
Latest News

Despite repeated calls for unity, democrats throw debate punches on health plans

Newsemia
Each candidate staked out a place on the health policy continuum but the biggest divide was between former Vice President Joe Biden — whose health...
Latest News

FDA expert panel gives thumbs-up to Aimmune’s peanut allergy drug

Newsemia
The FDA’s Allergenic Products Advisory Committee voted 7-2 in favor of supporting the efficacy profile of Palforzia, or AR101. Some committee members expressed concerns about...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy